Lipo Flavonoid Agreed to Modify Earwax Product Claims
The manufacturer will discontinue certain product performance claims after a review by the National Advertising Division.
Updated on Sept. 24, 2026 in Home Cleaning
Live Poll
Do you trust health and safety claims made in advertisements for over-the-counter wellness products?
Lipo Flavonoid LLC has agreed to update its marketing for the Earwax Cleansing Kit & Aid Drops following recommendations from the National Advertising Division (NAD). The move follows an industry challenge that questioned the accuracy of claims regarding how quickly the solution dissolves earwax and the safety of the product formula.
Why it matters
The decision ensures that consumer expectations for over-the-counter ear care products match verified scientific results rather than potentially unsubstantiated marketing language. The NAD determined that the company's submitted test data failed to support claims about safety, efficacy, and clinical testing.
The NAD evaluated claims against submitted in vitro tests and a Human Repeat Insult Patch Test. The manufacturer was specifically instructed to discontinue claims regarding dissolution speed, wax prevention, and its safe and gentle formula designation.
The players
National Advertising Division
An industry self-regulatory body that monitors the truthfulness and accuracy of national advertising claims.
Lipo Flavonoid LLC
The manufacturer of the Earwax Cleansing Kit & Aid Drops and other ear-care health products.
eosera, inc.
A competing ear-care product manufacturer that initiated the formal advertising challenge.
The details
The review process involved an evaluation of product packaging and advertising claims initiated by a challenge from eosera, inc. The NAD analyzed internal test data and survey results to determine if they substantiated the manufacturer's performance promises. Because the evidence did not support the specific assertions, the manufacturer has committed to permanently discontinuing those claims and modifying its doctor-recommendation messaging.
Timeline
Lipo conducted an otolaryngologist survey in late 2024.
The NAD issued its official recommendations on September 24, 2026.
The Home Front
This action follows the established pattern of the NAD using its monitoring protocols to demand evidence-based substantiation for health-product marketing. It highlights a broader regulatory trend of tightening oversight on the efficacy claims of over-the-counter household health goods.
When shopping for ear-care supplies, prioritize products with clearly listed active ingredients and third-party clinical data rather than relying solely on performance-speed marketing. If you have concerns about the safety or efficacy of a product currently in your home, consult with your primary care physician or a licensed ENT professional.
The takeaway
Marketing claims should never replace the advice of a medical professional when choosing health-related household supplies. Always cross-reference medical-device labels with your doctor before applying new treatments at home.
Further reading
For more tips on maintaining your medicine cabinet and household inventory, visit our Home Cleaning section.
Live Poll
Do you trust health and safety claims made in advertisements for over-the-counter wellness products?
